Brege Laura

CIK 000136561910 companiesFOSTER CITY, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001365619

Recent Transactions

50 trades

Award
Mirum Pharmaceuticals, Inc.$MIRM
Stock Option (right to buy)
2026-06-15+3,772→ 3,772 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Deferred Stock Units
2026-06-15+1,980→ 1,980 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2026-06-10+6,405→ 30,120 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2026-06-10+10,891→ 10,891 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2026-06-05+16,377→ 16,377 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2026-05-29+8,107→ 23,202 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2026-05-29−8,107→ 0 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2026-05-29+16,004→ 16,004 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2026-05-29+9,311→ 9,311 total
Exercise/Conversion
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2025-09-11$15.00/sh+17,000→ 32,703 total
Sale
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2025-09-11$74.34/sh−15,509→ 17,194 total
Sale
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2025-09-11$75.07/sh−1,491→ 15,703 total
Exercise/Conversion
Mirum Pharmaceuticals, Inc.$MIRM
Stock Option (right to buy)
2025-09-11−17,000→ 0 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2025-06-16+30,000→ 30,000 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2025-06-11+6,163→ 23,715 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2025-06-11+11,279→ 11,279 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-06-04$21.78/sh−14,446→ 15,095 total
Exercise/Conversion
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2025-05-29+5,703→ 15,703 total
Exercise/Conversion
Mirum Pharmaceuticals, Inc.$MIRM
Restricted Stock Units
2025-05-29−5,703→ 0 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Stock Option (right to buy)
2025-05-29+6,268→ 6,268 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Deferred Stock Units
2025-05-29+3,977→ 3,977 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2025-05-29+13,793→ 13,793 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2025-05-29+9,387→ 29,541 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2025-05-29−9,387→ 0 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2025-05-29+8,107→ 8,107 total
Purchase
Pacira BioSciences, Inc.$PCRX
Common Stock
2024-08-16$12.81/sh+1,000→ 17,552 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2024-06-12+5,230→ 16,552 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2024-06-12+12,179→ 12,179 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2024-06-10+20,594→ 20,594 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Stock Option (right to buy)
2024-06-05+8,779→ 8,779 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Restricted Stock Units
2024-06-05+5,703→ 5,703 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-05-29+9,387→ 9,387 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-05-29+6,652→ 20,154 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2024-05-29+15,959→ 15,959 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-05-29−6,652→ 0 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-06-14+1,775→ 11,322 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2023-06-14+12,925→ 12,925 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2023-06-12+22,123→ 22,123 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Stock Option (right to buy)
2023-06-12+17,000→ 17,000 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-06-12$24.87/sh−4,500→ 13,502 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-06-05$38.74/sh−600→ 9,547 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-06-01+8,552→ 18,002 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Director Stock Options (Right to Buy)
2023-06-01+11,045→ 11,045 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-06-01+6,652→ 6,652 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-06-01−8,552→ 0 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-04-03$29.90/sh+7,000→ 17,147 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2023-04-03−7,000→ 0 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-04-03$40.72/sh−7,000→ 10,147 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (Right to Buy)
2023-01-12−12,500→ 0 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-01-12$17.01/sh+12,500→ 12,500 total

Brege Laura

Recent Transactions

Companies

Recent Filings

Address